MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.13) by 34.92 percent. This is a 21.43 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $29.545 million which missed the analyst consensus estimate of $30.530 million by 3.23 percent. This is a 19.43 percent increase over sales of $24.739 million the same period last year.